Not recruiting
Small cell lung cancer
Not recruitingEvaluation of HLX10 Combined with Chemotherapy and Radiotherapy in Limited-Stage Small Cell Lung Cancer: A Phase III Randomized, Double-Blind Study
InvestigationalNo placebo
Evaluation of HLX10 Combined with Chemotherapy and Radiotherapy in Limited-Stage Small Cell Lung Cancer: A Phase III Randomized, Double-Blind Study
InvestigationalNo placebo
- Disease:Small cell lung cancer
- Substances:Serplulimab
Countries:
Austria
Austria- Participants:18–64 years · 65+ years
- Substances:Serplulimab



